Target intelligence / Profile preview

Non-specific inflammatory mediators and tissue substrates

Molecular classification
Other
01

Overview

Non-specific inflammatory mediators and tissue substrates is a broad pharmacological category rather than a single molecular entity. It encompasses a wide array of endogenous substances, including cytokines, prostaglandins, and histamines, as well as the physical components of the extracellular matrix and cellular membranes involved in the inflammatory response (DrugBank, 2024). This classification is frequently used for topical agents and counter-irritants, such as camphor and menthol, which exert therapeutic effects by modulating multiple pathways simultaneously or by providing physical protection and soothing to damaged tissues (StatPearls, 2023). Because this 'target' lacks a specific protein structure, it does not fit the traditional definition of a drug target used in modern rational drug design. Instead, it serves as a catch-all term for agents with pleiotropic or poorly characterized modes of action in the context of inflammation and pain management (PubMed, PMC4124736). These agents often work by altering the local environment or stimulating sensory nerves to provide symptomatic relief. Consequently, the term is more descriptive of a physiological state or a group of reactants than a specific site of drug action. This category is primarily relevant in the context of over-the-counter dermatological and analgesic products.

Other names
Inflammatory mediatorsTissue substratesNon-specific targetsNon-specific inflammatory mediators
02

Mechanism of action

Drugs targeting this category typically act through non-specific mechanisms such as counter-irritation, local cooling or warming sensations, physical barrier formation, or broad modulation of inflammatory signaling pathways without binding to a single specific receptor or enzyme.

03

Biological functions

Immune responseInflammationTissue repairSignal transduction
04

Disease associations

InflammationPainInfectionDermatitisPruritus
05

Safety considerations

Local skin irritationContact dermatitisSystemic toxicity upon excessive absorptionLack of pharmacological specificityHypersensitivity reactionsRisk of chemical burns with high concentrations
06

Interacting drugs

Camphor

10 more in the full profile.

07

Biomarkers

C-reactive proteinInterleukin-6Tumor necrosis factor-alphaErythrocyte sedimentation rateProstaglandin E2Leukotriene B4

Beyond the preview

Go deeper on Non-specific inflammatory mediators and tissue substrates.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific inflammatory mediators and tissue substrates.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call